Amalgamated Bank’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-394
| Closed | -$2K | – | 3148 |
|
|
2024
Q1 | $2K | Sell |
394
-554
| -58% | -$2.81K | ﹤0.01% | 2908 |
|
|
2023
Q4 | $5K | Sell |
948
-117
| -11% | -$617 | ﹤0.01% | 2950 |
|
|
2023
Q3 | $17K | Hold |
1,065
| – | – | ﹤0.01% | 2742 |
|
|
2023
Q2 | $21K | Sell |
1,065
-3,492
| -77% | -$68.9K | ﹤0.01% | 2736 |
|
|
2023
Q1 | $129K | Sell |
4,557
-107
| -2% | -$3.03K | ﹤0.01% | 1951 |
|
|
2022
Q4 | $136K | Sell |
4,664
-495
| -10% | -$14.4K | ﹤0.01% | 2007 |
|
|
2022
Q3 | $136K | Sell |
5,159
-147
| -3% | -$3.88K | ﹤0.01% | 2005 |
|
|
2022
Q2 | $236K | Buy |
5,306
+10
| +0.2% | +$445 | ﹤0.01% | 1801 |
|
|
2022
Q1 | $262K | Sell |
5,296
-340
| -6% | -$16.8K | ﹤0.01% | 1825 |
|
|
2021
Q4 | $287K | Sell |
5,636
-264
| -4% | -$13.4K | ﹤0.01% | 1848 |
|
|
2021
Q3 | $329K | Sell |
5,900
-97
| -2% | -$5.41K | ﹤0.01% | 1805 |
|
|
2021
Q2 | $257K | Buy |
+5,997
| New | +$257K | ﹤0.01% | 1950 |
|